Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 1999
View Archived Issues
Company Profile: Alliance
Read More
Company Profile: Innogenetics
Read More
Genentech: Q4 and year-end 1998 highlights
Read More
Licensing opportunity from NIH: monomeric and dimeric arylisoquinoline alkaloids
Read More
Amide antibacterial agents with potential in gastric disorders in development at Mitsubishi
Read More
Novel antiallergic agents from Nissan act as both substance P and histamine antagonists
Read More
Hokuriku Seiyaku presents broad-spectrum antibacterial agents with good safety
Read More
Licensing opportunity from NIH: inhibitory and immunoblotting MAb specific for P-450 2A6
Read More
Hypoglycemic/hypoinsulinemic chromium complexes designed at Otsuka
Read More
Anti-H. pylori agents under investigation at Bayer
Read More
WHO maintains importance of male contraceptive research
Read More
Subunit-selective GABA-A receptor ligands for anxiety, convulsions reported by MS&D
Read More
More 5-HT4 receptor ligands in development at Synthelabo
Read More
New findings on the role of IFN-alpha in diabetes reported
Read More
Preclinical study results support development of antiulcer agent TU-199
Read More
Acupuncture and amitriptyline do not provide pain relief in HIV-related peripheral neuropathy
Read More
Trimeris to present preliminary phase II trial results of T-20
Read More
Synthelabo reports recent events in R&D
Read More
Japanese authorities approve Viagra
Read More
Deltagen to validate target genes for Roche Bioscience
Read More
Patent coverage sought by Viragen for second-generation interferon product
Read More
Studies in knockout mice support the role of CB1 receptor in opiate addiction
Read More
BTG enters agreement with Novo Nordisk for pain and epilepsy compounds
Read More
Iron chelator enhances ALA PDT efficacy in rat colon
Read More
Pharmadigm enters agreement with Mipharm for PB-005
Read More
Pharmacia & Upjohn's antiparkinsonian approved in Spain
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe